Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
TOP
Print Edition
We will request your mailing address on the next page.
TOP
E-Newsletters and Communications
JHOP
Print Edition
We will request your mailing address on the next page.
JHOP
E-Newsletters and Communications
I have reviewed and consent to the terms of
TOP
's
Privacy Policy
, and
TOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe
Home
Issues
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 3
August 2018 - Vol 11 No 2
May 2018 - Vol 11 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
Year End Review 2019
Web Exclusives
Ovarian Cancer Overview
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Interview with the Innovators
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Meg Barbor, MPH
Authored Items
Oncology Biosimilars: 2020 Update
Meg Barbor, MPH
TOP - July 2020, Vol 13, No 4
in
Biosimilars
International Society of Cannabis Pharmacists Plans to Hold Inaugural Meeting in 2020
Meg Barbor, MPH
TOP - May 2020, Vol 13, No 3
in
Medical Marijuana
Biosimilars Are Key Components of Oncology Today: Brush Up on the Basics
Meg Barbor, MPH
TOP - March 2020, Vol 13, No 2
in
Biosimilars
Selecting Treatment for Relapsed/Refractory Multiple Myeloma in the Era of Multiple Choices
Meg Barbor, MPH
TOP - January 2020, Vol 13, No 1
in
Hematologic Cancers
Genetic Profiling and Personalized Medicine in Myelodysplastic Syndromes
Meg Barbor, MPH
TOP - January 2020, Vol 13, No 1
in
Hematologic Cancers
Engaging Patients in Their Cancer Care Through Digital Health
Meg Barbor, MPH
TOP - November 2019, Vol 12, No 4
in
MASCC/ISOO Conference Highlights
Neurofeedback Reduces Symptoms of CIPN
Meg Barbor, MPH
TOP - November 2019, Vol 12, No 4
in
MASCC/ISOO Conference Highlights
Oral Cancer and Sex in the Era of HPV Infection
Meg Barbor, MPH
Web Exclusives
in
Head and Neck Cancer
The Evolving Role of Precision Medicine in Clinical Practice
Meg Barbor, MPH
TOP - August 2019, Vol 12, No 3
in
HOPA
New HOPA Committee Aims to Improve Patient Outreach Services
Meg Barbor, MPH
TOP - May 2019, Vol 12, No 2
in
HOPA
Applying Business Principles to Everyday Practice
Meg Barbor, MPH
TOP - May 2019, Vol 12, No 2
in
HOPA
Current Strategies in the Management of CINV
Meg Barbor, MPH
TOP - May 2019, Vol 12, No 2
in
HOPA
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery
Meg Barbor, MPH
TOP - February 2019, Vol 12, No 1
in
Symptom Management
The Pharmacist’s Role in Improving Quality in Oncology
Meg Barbor, MPH
TOP - November 2018, Vol 11, No 3
in
HOPA
CAR T-Cell Therapy: Can We Afford the Cure?
Meg Barbor, MPH
TOP - November 2018, Vol 11, No 3
in
HOPA
Harnessing the Power of Business Intelligence to Influence Oncology Practice
Meg Barbor, MPH
TOP - November 2018, Vol 11, No 3
in
HOPA
Cannabis for Symptom Management in Cancer: Do You Know What Your Patients Are Using?
Meg Barbor, MPH
TOP - November 2018, Vol 11, No 3
in
Symptom Management
Updates on Immunotherapy in Advanced Melanoma
Meg Barbor, MPH
TOP - May 2018, Vol 11, No 1
in
Melanoma
,
HOPA
Understanding Immunotherapy Late Adverse Effects in Cancer Survivors
Meg Barbor, MPH
TOP - May 2018, Vol 11, No 1
in
Side-Effects Management
,
Side-Effects Management
Targeting FMS-Like Tyrosine Kinase 3 in the Management of Patients with FLT3-Positive Acute Myeloid Leukemia
Meg Barbor, MPH
TOP - May 2018, Vol 11, No 1
in
Leukemia
,
HOPA
The Strengths and Pitfalls of PD-L1 as a Biomarker for Immunotherapy
Meg Barbor, MPH
TOP - May 2018, Vol 11, No 1
in
HOPA
New Drug Therapies for Relapsed or Refractory Multiple Myeloma
Meg Barbor, MPH
TOP - August 2017, Vol 10, No 3
in
Multiple Myeloma
Evidence Supports the Use of Aspirin for Precision Chemoprevention of Colorectal Cancer
Meg Barbor, MPH
TOP - August 2017, Vol 10, No 3
in
Colorectal Cancer
Managing Immune-Related Toxicities in Patients with Lung Cancer
Meg Barbor, MPH
TOP - May 2017, Vol 10, No 2
in
Lung Cancer
Novel Cytotoxic Drugs Still Play an Important Role in the Treatment of Lung Cancer
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1
in
Lung Cancer
Improved Patient Adherence in a Pharmacy-Led Oral Chemotherapy Program
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1
in
Conference Correspondent
Is Value-Based Pricing the Solution to Unaffordable Anticancer Drugs?
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1
in
Conference Correspondent
Immunotherapy for the Treatment of Patients with Malignant Pleural Mesothelioma
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1
in
Immunotherapy
Delirium Symptoms More Severe in Patients Treated with Antipsychotics
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1
in
Palliative Care
Transitioning from Inpatient to Outpatient Chemotherapy Saves Money, Increases Patient Satisfaction
Meg Barbor, MPH
TOP - February 2017, Vol 10, No 1
in
Conference Correspondent
Challenges in ALK-Positive NSCLC Management
Meg Barbor, MPH
Online First
in
Conference Correspondent
Lowering the High Cost of USP 800 Compliance
Meg Barbor, MPH
Online First
Posters of Interest from the 2016 MASCC/ISOO Annual Meeting
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Conference Correspondent
Probiotics Hold Promise for Preventing Radiation Enteropathy
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Supportive Care
SGX942 Decreases Duration of Severe Oral Mucositis in Patients with Head and Neck Cancer
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Supportive Care
Managing Delirium in Patients with Cancer
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Supportive Care
Treating Nausea as a Symptom Cluster
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Supportive Care
Challenges in ALK-Positive Non–Small-Cell Lung Cancer Management
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Conference Correspondent
Certain Measures Can Lower the High Cost of USP 800 Compliance
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Conference Correspondent
USP 800: Navigating the New Requirements for Handling Hazardous Drugs
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Conference Correspondent
“Magic Mouthwash” for mTOR Inhibitor–Associated Stomatitis?
Meg Barbor, MPH
TOP - November 2016, Vol 9, No 4
in
Supportive Care
The New World of Biosimilars
Meg Barbor, MPH
TOP - August 2016, Vol 9, No 3
An Update on CancerLinQ—ASCO’s Big Data Cancer Database
Meg Barbor, MPH
TOP - August 2016, Vol 9, No 3
Molecular Profiling Is Vital in Patients with Metastatic Cancer
Meg Barbor, MPH
TOP - August 2016, Vol 9, No 3
Low-Level Laser Therapy Reduces Pain in Patients with Head and Neck Cancer
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2
in
Head and Neck Cancer
Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2
in
Head and Neck Cancer
Prophylactic Gabapentin Linked to Weight Loss, Narcotic Dependency
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2
in
Conference Correspondent
,
Head and Neck Cancer
Lower Readmission Rates Associated with Pharmacist-Assisted Transitional Care Program
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2
in
Conference Correspondent
ASHP Foundation Forecast Provides Actionable Recommendations for Pharmacy Leaders
Meg Barbor, MPH
TOP - February 2016, Vol 9, No 1
in
Practical Issues for Pharmacists
Aprepitant Reduces Cough Severity in Patients with Lung Cancer
Meg Barbor, MPH
TOP - February 2016, Vol 9, No 1
in
Lung Cancer
Aspergillus and the Azoles in 2015
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4
in
Supportive Care
Intravenous Iron Better Tolerated Than Oral Iron for Chemotherapy-Induced Anemia
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4
in
Conference Correspondent
Successful Navigation of Oncology Pharmacy Services Affiliation Agreements
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4
in
Conference Correspondent
The Perceptual Gap in the Impact of Chemotherapy- and Radiotherapy-Induced Nausea and Vomiting
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4
in
Supportive Care
Docetaxel plus Nintedanib Tolerated in Patients with NSCLC
Meg Barbor, MPH
TOP November 2015 Vol 8 No 4
in
Conference Correspondent
Rolapitant Effective for Chemotherapy-Induced Nausea and Vomiting
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3
in
Conference Correspondent
Pharmacy Services: Successful Navigation of Oncology Pharmacy Services Affiliation Agreements
Meg Barbor, MPH
Web Exclusives
in
Practical Issues for Pharmacists
Developing a Pharmacist-Driven Drug-Monitoring Protocol
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3
in
Conference Correspondent
Late Toxicities in Pediatric Cancer Care
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3
in
Pediatric Cancer
Meeting USP Chapter 800 Head On
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3
in
Conference Correspondent
Osteonecrosis of the Jaw Associated with Medication, Not Extraction
Meg Barbor, MPH
TOP - August 2015, Vol 8, No 3
The Ins and Outs of Disposing Oral Cancer Drugs
Meg Barbor, MPH
TOP - May 2015, Vol 8, No 2
in
Conference Correspondent
Shift Work, Sleep Deprivation, and Cancer Risk
Meg Barbor, MPH
TOP - May 2015, Vol 8, No 2
in
Best Practices
The Pharmacist’s Role in Hospice and Palliative Care
Meg Barbor, MPH
TOP - May 2015, Vol 8, No 2
in
Conference Correspondent
Pharmacists Can Play an Active Role in Survivorship Care
Meg Barbor, MPH
TOP - May 2015, Vol 8, No 2
in
Survivorship
Effective Lung Cancer Screening
Meg Barbor, MPH
TOP - February 2015, Vol 8, No 1
in
Lung Cancer
Vaginal DHEA May Improve Sexual Function in Women With Breast/Gynecologic Cancer
Meg Barbor, MPH
TOP - October 2014, Vol 7, No 4
in
Supportive Care
The Psychosocial Effects of Chemotherapy-Induced Alopecia
Meg Barbor, MPH
TOP - October 2014, Vol 7, No 4
in
Supportive Care
Positive Patient Outcomes Observed With a Pharmacist- Physician Collaboration in a Palliative Care Outpatient Practice
Meg Barbor, MPH
TOP - August 2014, Vol 7, No 3
in
Best Practices
Last modified: February 13, 2020
Home
Issues
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 3
August 2018 - Vol 11 No 2
May 2018 - Vol 11 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
Year End Review 2019
Web Exclusives
Ovarian Cancer Overview
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Interview with the Innovators
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
